Related articles:
Imatinib
Sorafenib
Renal cell carcinoma
Gastrointestinal stromal tumor
Pfizer
Vascular endothelial growth factor
Key terms:
sunitinib
patients
tumor
cancer
gist
rcc
phase
dose
therapy
placebo
px
imatinib
lab
receptor
adverse events
fatigue
receiving
nice
respond
median
efficacy
ester
renal
inhibits
pfizer
medicare
phase iii
ullrich
patients who
metastatic
sunitinib patients
diarrhea
phase ii study
tyrosine kinase
kidney cancer
stomatitis
donut hole
placebo patients
overall survival
these patients
sunitinib step
disease progression
tumor shrinkage
primary endpoint
over to sunitinib
receptor tyrosine
patients receiving
objective response
gastrointestinal stromal tumor
associated with sunitinib therapy
Search external links cited by footnotes on Wikipedia page Sunitinib:
|
|